Phase 3Completed
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis (PNE)
A Double-blind, Placebo-controlled, Phase III Comparative Study With FE992026 in Children and Adolescents With Reduced Night-time Urinary Osmolarity-type Nocturnal Enuresis
- Sponsor
- Ferring Pharmaceuticals (Industry)
- Enrollment
- 89 enrolled
- Conditions
- Nocturnal Enuresis
- Interventions
- Desmopressin; Placebo
- Ages
- children
- Registry
- NCT01078753
Full record on ClinicalTrials.gov
From the registry
This is multi-center, randomized, placebo-controlled, parallel-group, double-blind, dose-escalating clinical trial designed to assess the efficacy and safety of desmopressin orally lyophilisate for the treatment of nocturnal enuresis "with decreased nighttime urinary osmolality."
Primary outcomes
- Change in the Number of Wet Nights Between Baseline and Treatment Period II
History
Results first posted
Last registry update
Primary completion
Registered
Started